Stella Mental Health Welcomes Two New Board Members to Support Growth and Innovation in Interventional Psychiatry

CHICAGO, June 30, 2025 /PRNewswire/ -- Stella Mental Health, a national leader in interventional psychiatry, today announced the appointment of two new members to its Board of Directors: Nick Cortezi, entrepreneur and founder of All Risks Ltd and Hadar Levy,Chief Executive Officer of BrainsWay.

Cortezi and Levy bring a wealth of expertise in healthcare innovation, strategic growth, and scaling mission-driven organizations—experience that will be invaluable as Stella expands access to evidence-based mental health treatments across the U.S. and globally.

"We are honored to welcome both Nick and Hadar to our board at such a pivotal time in Stella's growth," said Michael Gershenzon, co-founder and CEO of Stella Mental Health. "Their vision, experience, and passion for transforming health care will help accelerate our mission to make interventional psychiatry more accessible and affordable for those suffering from trauma-related conditions like PTSD/PTSI, anxiety, and depression."

Cortezi is a seasoned entrepreneur and investor who built All Risks, Ltd. into one of the largest specialty insurance brokerage firms in the country before its merger with Ryan Specialty Group. A longtime advocate for innovation in healthcare, Cortezi brings strategic insight and operational leadership to Stella as it scales new care models and expands its national footprint.

Hadar Levy is the Chief Executive Officer of BrainsWay, a global leader in advanced, non-invasive treatments for mental health disorders. With more than two decades of experience in neuroscience and global commercial strategy, Levy is widely regarded as a pioneer in the commercialization of transcranial magnetic stimulation (TMS) technologies. His addition to the board reinforces Stella's commitment to cutting-edge, multimodal treatment solutions that address the biological root causes of mental illness.

These appointments reflect Stella's commitment to pioneering multimodal treatments that address the biological root causes of mental health conditions. The company currently operates more than 20 clinics across the U.S. and abroad, offering cutting-edge treatments including theDual Sympathetic Reset (DSR) stellate ganglion block (SGB), transcranial magnetic stimulation (TMS), Spravato® (esketamine), ketamine infusion therapy, psychotherapy, and medication management.

Just before the announcement of Stella receiving a $5M investment from BrainsWay, Stella launched a nationwide affordability initiative, substantially reducing the cost of self-pay services, and has expanded into insurance-covered care. The organization has also expanded its partner roster—including with the City of Chicago, the 100 Club of Illinois, and the Ministry of Defense in Israel—to expand access for trauma survivors and first responders.

"Stella is charting a new path in mental health care—one rooted in science, driven by compassion, and powered by innovation," added Gershenzon. "Nick & Hadar's involvement will help ensure we scale this model with excellence and integrity."

Cortezi and Levy will join a board of distinguished healthcare and business leaders, including Pat Basu, former President and CEO of Cancer Treatment Centers of America and Board Member at CareCredit;Steven Taslitz, Chairman and Co-Founder of Sterling Partners; and Murray Brozinsky, former CEO of Conversa.

For more information, new pricing, and locations, visit www.stellamentalhealth.com.

About Stella:
Stella is a leading Interventional Psychiatry practice committed to transforming mental health care through advanced, evidence-based protocols for severe trauma, stress, anxiety, depression, and post-traumatic stress injury (PTSI). With a multidisciplinary team of board-certified physicians, advanced psychiatric nurse practitioners, psychologists, psychiatrists, and dedicated advocates, Stella integrates cutting-edge biological, psychological, and psychiatric approaches to deliver personalized care.

MEDIA CONTACT:
Daphne Ortiz
312.488.3472
397402@email4pr.com

View original content:https://www.prnewswire.com/news-releases/stella-mental-health-welcomes-two-new-board-members-to-support-growth-and-innovation-in-interventional-psychiatry-302494389.html

SOURCE Stella Mental Health